Pharmaceutical Accountability Foundation

Home Tags Leadiant

Tag: Leadiant

AMSTERDAM, THE NETHERLANDS: The District Court of Rotterdam has rejected the appeal of pharmaceutical company Leadiant against the 2021 decision of the Netherlands Competition...
AMSTERDAM: The Pharmaceutical Accountability Foundation (PAF), a group of legal and medical experts and public health advocates, today welcomes the news that the Spanish...
As an international student I have always sought out opportunities to meet local people and to broaden my personal and professional network. When provided with...
Bergeijk, June 2, 2022 The Italian Competition Authority (ICA) decided on 31 May that pharmaceutical company Leadiant has charged the Italian National Health Service excessive...
On 27 January we hosted the second part of our webinar series The Power of Law. This second part was dedicated to presenting our...
On 17 november, Wilbert Bannenberg, chair of the Pharmaceutical Accountability Foundation, presented at the regional Access to Medicines Dialogue of the EU Alliance. The...
Bergeijk, July 19, 2021 On September 7, 2018, the Pharmaceutical Accountability Foundation (PAF) submitted an enforcement request  for abuse of a dominant market position by...
The Pharmaceutical Accountability Foundation welcomes the news that the Amsterdam UMC (Amsterdam University Medical Centers) has resumed supplying Dutch patients with the rare disease...